When is alkaline phosphatase isoenzyme fraction testing indicated and how are the results interpreted to identify the source of an elevated alkaline phosphatase?

Alkaline Phosphatase Isoenzyme Fraction Testing

When to Order Isoenzyme Testing

Measure gamma-glutamyl transpeptidase (GGT) first rather than ordering alkaline phosphatase isoenzyme fractionation when evaluating an isolated elevated ALP. 1 GGT is the preferred initial test because it is simpler, less expensive, and effectively distinguishes hepatic from non-hepatic sources of elevated ALP. 1

Clinical Algorithm for Elevated ALP

Step 1: Confirm hepatic origin

• Order GGT alongside the elevated ALP 1
• If GGT is elevated: ALP is of hepatic origin; proceed to imaging of the biliary tree 1
• If GGT is normal: Consider bone disease (Paget's disease, bony metastases, fracture) or physiologic elevation (childhood growth, pregnancy) 1

Step 2: Check for concurrent transaminase elevation

• If ALT/AST are also elevated, this confirms liver disease and isoenzyme testing adds no value 2
• The combination of elevated transaminases with elevated ALP is as useful as isoenzyme determination for identifying liver disease 2

Step 3: Consider isoenzyme fractionation only when:

• ALP is elevated in isolation without clear clinical context 2, 3
• GGT results are equivocal or unavailable 3
• You need to differentiate between bone and liver sources when both could be present 4, 5

Important Caveats

Common pitfall: Ordering isoenzyme fractionation routinely for all elevated ALP values wastes resources. 2 The test has limited accuracy—the liver isoenzyme fraction has only 68% positive predictive value for liver disease, though bone isoenzyme has 93% positive predictive value when positive. 2

Age and sex matter: Normal total ALP does not rule out abnormal isoenzyme patterns, particularly in children. 4 Always use age- and sex-appropriate reference ranges when interpreting results. 4

Interpretation of Isoenzyme Results

Hepatic Isoenzymes

Liver-origin ALP appears in multiple forms: 4, 5

• Soluble liver ALP (Sol-liver)
• Membrane-bound liver ALP (Mem-liver)
• Lipoprotein-bound liver ALP
• High molecular weight liver cell membrane fragments that remain at the electrophoresis origin in cholestatic disease 5

Clinical significance:

• Elevated liver isoenzymes indicate cholestasis from extrahepatic obstruction (choledocholithiasis, malignant obstruction, strictures) or intrahepatic disease (primary biliary cholangitis, primary sclerosing cholangitis, drug-induced cholestasis) 1
• Infiltrative diseases (sarcoidosis, amyloidosis, hepatic metastases) also elevate liver ALP 1
• Proceed to abdominal ultrasound as first-line imaging to assess for biliary ductal dilatation and gallstones 1

Bone Isoenzymes

Bone-origin ALP includes: 4

• Soluble bone ALP (Sol-bone)
• Anchor-bearing bone ALP (Anch-bone)

Clinical significance:

• Elevated bone isoenzymes indicate increased osteoblastic activity 4, 6
• Consider Paget's disease, bony metastases, fractures, or metabolic bone disease 1
• Bone isoenzyme is heat-labile and denatures at 56°C, which helps differentiate it from liver isoenzyme on electrophoresis 5

Intestinal Isoenzyme

Intestinal ALP (Sol-intestinal): 4, 5

• Normally present in small amounts in blood groups B and O
• May be elevated in cirrhosis and certain liver diseases 5
• Less clinically significant than liver or bone fractions 4

Imaging After Isoenzyme Identification

If liver isoenzyme is elevated:

• First-line: Abdominal ultrasound to evaluate for biliary ductal dilatation and choledocholithiasis 1
• If US shows ductal dilatation: MRI with MRCP is the most useful modality for evaluating etiology of biliary obstruction 1
• If US is negative but ALP persistently elevated: Consider MRI with MRCP for intrahepatic cholestatic processes 1

If bone isoenzyme is elevated:

• Pursue bone-specific imaging and evaluation for metabolic bone disease, malignancy, or Paget's disease 1